You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
3 May 2022
Perrigo has completed its previously-announced acquisition of French consumer healthcare company HRA Pharma for EUR1.8 billion (USD1.9 billion) in cash.
7 March 2022
French consumer healthcare company HRA Pharma reported sales up by 26.0% in 2021.
24 February 2022
Perrigo’s agreed acquisition of HRA Pharma has won the OTCToolbox Consumer Healthcare Industry (CHi) Award for Transaction of the Year.
24 February 2022
HRA Pharma’s Hana and Maxwellia’s Lovima are joint winners of the OTCToolbox Consumer Healthcare Industry (CHi) Award for Innovation of the Year.
8 September 2021
Perrigo is acquiring French consumer healthcare company HRA Pharma from Astorg and Goldman Sachs Asset Management for EUR1.8 billion (USD2.1 billion) in cash.
9 July 2021
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for two oral contraceptive pills – HRA Pharma’s Hana and Maxwellia’s Lovima – to be sold without a prescription. Michelle Riddalls – chief executive officer of the Proprietary Association of Great Britain (PAG...
25 February 2021
HRA Pharma picks up the OTCToolbox Consumer Healthcare Industry (CHi) Award for Regulatory Achievement of the Year for a “milestone achievement” with its ellaOne brand in Italy.
15 February 2021
Two applications to switch oral contraceptives from prescription-only to pharmacy (POM to P) status in the UK are now out for consultation. If they are approved, then Maxwellia’s Lovima and HRA Pharma’s Hana will become the country’s first OTC oral contraceptive pills.